InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: learning curve post# 72744

Tuesday, 01/27/2015 10:24:21 PM

Tuesday, January 27, 2015 10:24:21 PM

Post# of 80868
the stock is not going to $20 without changes.

The management should realize that Musclepharm is no different than Joe's Jeans, FXCM or any other small company that takes great risks.

Musclepharm does run a too tight operation and it relies too much on issuing stocks for paying for executives and for advertising. This has hurt the perception of the company to the SEC, to investors and to creditors.

The reputation, the corporate governance, the corporate culture and the branding are all things that need to be improved going forward....otherwise, Musclepharm will remain to be a penny stock.

Also, Musclepharm needs to deploy it's resources to the fullest. Tiger Woods is a resource which Musclepharm employees gotta synthesize with other resources of the company to create something magnificent. I don't work for Musclepharm, so they gotta figure it out.